Chris Johnson Email & Phone Number

Holly Springs, NC, US

Raleigh, North Carolina, United States

- Led and managed strategic and programmatic initiatives to achieve new Member and new Board of Advisors goals working with our staff, Board of Directors, Board of Advisors, and Ambassadors Committee to recruit Technology, Professional Services, Non-Profit/Government/Education, and Tech-Enabled organizations. - Achieved in 2023 the highest additions of new.

- Led the PERSERIS team to accomplish commercial goals and objectives in the treatment of schizophrenia.- Developed strategic, promotional, and programmatic marketing initiatives managing to a $6M budget.

- Led team of 10 sales professionals in Eastern NC to accomplish VBU sales objectives and priorities accomplishing top 10% US ranking in 2019 and 2020- Managed $100M portfolio via clinical, organizational, and financial B2B vaccines sales in major NC health systems and adult /pediatric practices exceeding year-on-year volume growth goals- Developed key.

- Led new business entry and account management in major NC health systems and affiliated practices: Duke, UNC, WakeMed, Vidant, First Health Carolinas.- Vaccines Performance Circle Award Winner for 4 consecutive years (2014-2017)

- Led new business entry in adult practices across NC with launch of a new product indication including innovative clinical, financial, and organizational positioning of portfolio offering.- Vaccines Performance Circle Award Winner in 2013

- Directed Acne/AB franchises and team comprised of 4 brand leaders responsible for ~$300M or 50% of the US Rx Dermatology business- Developed life-cycle management strategy to sustain sales of LEXIVA in the crowded 3rd agent HIV market- Developed epilepsy market entry strategies, positioning, & commercialization for POTIGA 4Q09 New Drug Application (NDA).

- Managed LAMICTAL marketing team comprised of 10 brand leaders. Achieved 6 consecutive years +25% growth from $312M (2001) to peak $2.2B (2007) rising to 2nd largest brand at GSK- Launched 4 new product entries in LAMICTAL leading cross-functional teams to achieve FDA filings from approvable to approval- Developed strategic lifecycle plan achieving.

- Led development of the epilepsy portfolio life cycle management strategy for LAMICTAL, LAMICTAL XR, and LAMICTAL ODT- Managed $22M portfolio Advertising & Promotion budget to within 1% accuracy

- Planned and executed epilepsy marketing strategies/tactics for professionals, patients, and payers- Led selection and management of advertising agency - achieved lowest copy approval re-work rate at GSK- GSK Marketing Excellence Award 2003

- Directed all professional and consumer marketing activities with 30 major respiratory and PCP associations- Developed KOL programs, communications and advisory boards to successfully launch ADVAIR

- Recommended by senior management as commercial representative to R&D for special "Molecule to Market" secondment assignment- Integrated commercialization strategic insights and project planning into global drug development

- Developed market research and strategies to achieve access for in-line products in key payer segments- Created and implemented an Opportunity Rx model to identify optimal accounts for in-line product growth- Glaxo Wellcome President's Club - Marketing in 1998

- Managed account team assigned to 40 large employers representing 100,000 members/$12.2M in sales- New business entry in private employers increased 25%

- Led cross-matrix team submission of first-ever NC Medicaid Managed Care request-for-proposal response- Developed new proposal system project flow to reduce turnaround time of RFP responses by 20%

- Appointed to staff NC Governor’s Legislative Commission responsible for NC health policy decisions- Led three policy committees on Managed Care, Rural Health, Technology in Health Care

- Specialty sales to urologists and endocrinologists in NC and SC- Ranked 3rd nationally achieving 108% of sales goal

- Developed in-line and new product financial, marketing, and manufacturing forecasts for over 300 products- Created “Opportunity-Rx” sales model to target sales and achieve 106% performance to goal

Summer internships in 1989 and 1987